Novartis Sues Janssen for Claiming Superiority of Its Psoriasis Drug

Drug Industry Daily
A A
Novartis filed a lawsuit on Friday accusing Janssen of falsely claiming that its plaque psoriasis drug Tremfya (guselkumab) is superior to Novartis’ product, Cosentyx (secukinumab).

To View This Article:

Login

Subscribe To Drug Industry Daily